Description

Description

Galvecta Plus is a fixed-dose combination medicine manufactured by PharmaEvo, formulated with two active ingredients — Vildagliptin (50mg) and Metformin (500mg) — in each tablet. This pack contains 14 tablets designed for adults managing type 2 diabetes mellitus who require a dual-action approach to blood sugar control. By combining two medicines with different mechanisms of action into a single tablet, Galvecta Plus offers a more convenient treatment option for patients whose blood sugar is not adequately controlled on Metformin alone, or for those already stabilized on both medicines separately at matching doses. Vildagliptin, a DPP-4 inhibitor, works by increasing levels of natural hormones that help the pancreas release more insulin when blood sugar is high while also reducing glucose production by the liver, and it carries a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. Metformin complements this by further reducing liver glucose output and improving the body’s sensitivity to insulin. Together, these two mechanisms support more comprehensive glycemic control. Galvecta Plus is intended to be used alongside lifestyle measures such as a controlled diet, regular physical activity, and consistent blood sugar monitoring, and should only be taken under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Galvecta Plus contains two active pharmaceutical ingredients: Vildagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 500mg, a biguanide-class medicine that helps regulate liver glucose production and improves insulin sensitivity in body tissues. The tablet formulation also contains standard pharmaceutical excipients, including binding and coating agents, which support tablet integrity, stability, and consistent release of the active ingredients.

Dosage Form

Galvecta Plus is available as an oral film-coated tablet, with each tablet containing a combined strength of 50mg Vildagliptin and 500mg Metformin. The pack contains 14 tablets, offering a supply typically aligned with short-term prescription cycles or as directed by a treating physician.

Uses

Galvecta Plus is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly in cases where treatment with Metformin alone has not provided adequate glycemic control, or where a doctor determines that combination therapy with a DPP-4 inhibitor would be beneficial. It is generally prescribed as part of a broader diabetes management plan and may be used alongside other antidiabetic therapies depending on individual patient requirements. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Galvecta Plus tablets are typically taken twice daily with meals, as directed by a physician, to help reduce the likelihood of gastrointestinal discomfort associated with Metformin. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically advised. The exact dosage, frequency, and duration of treatment should be determined by a healthcare provider based on individual blood sugar levels, kidney and liver function, and response to therapy. If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Galvecta Plus may cause side effects in some individuals, and not all users will experience them. Commonly reported effects include gastrointestinal disturbances such as nausea, diarrhea, or stomach discomfort, particularly during the initial period of use, along with dizziness and headache associated with the Vildagliptin component. Some patients may also experience mild joint discomfort or a metallic taste in the mouth. In rare instances, more serious effects such as lactic acidosis (linked to Metformin), significant liver problems, or pancreatitis (linked to Vildagliptin) have been reported, and immediate medical attention should be sought if symptoms such as severe abdominal pain, unusual fatigue, persistent nausea, or yellowing of the skin or eyes occur.

Pregnancy & Breastfeeding

Galvecta Plus is generally not recommended during pregnancy. While Metformin has been used in certain pregnancy-related conditions under close medical supervision, the safety of Vildagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning to become pregnant, or suspect pregnancy should consult their doctor immediately. For breastfeeding mothers, the safety of this combination has not been well established, and alternative diabetes management options are usually considered during this period. Any decisions regarding use during pregnancy or breastfeeding should be made exclusively in consultation with a healthcare provider.

Storage Instructions

Galvecta Plus tablets should be stored at room temperature in a cool, dry place, away from direct sunlight, heat, and moisture. Tablets should remain in their original packaging until use to protect them from environmental exposure. Keep out of reach of children and pets, and avoid using the medication beyond its printed expiry date. Expired or unused tablets should be disposed of responsibly, following local pharmaceutical waste disposal guidelines rather than being discarded in regular household trash.

FAQs

Can Galvecta Plus replace two separate medicines I’m currently taking?
In many cases, yes, if your doctor has prescribed both Vildagliptin and Metformin separately at matching doses, but this switch should only be made under medical guidance.

Does Galvecta Plus cause low blood sugar?
The risk of hypoglycemia with this combination is relatively low compared to some other diabetes medicines, though it can still occur, particularly if combined with additional antidiabetic therapies.

Does Galvecta Plus cause stomach upset?
Metformin, one of its components, may cause mild gastrointestinal discomfort initially, which often improves when taken with food and over time.

Is Galvecta Plus suitable for patients with liver or kidney issues?
Both active ingredients require adequate liver and kidney function for safe use, so patients with existing conditions should be evaluated carefully by their doctor before starting this medicine.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.